HER WORLD / HARPER’S BAZAAR / FEMALE ADVERTORIAL DECEMBER 2020

References:

Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  1. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.
  2. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373
  3. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  4. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  5. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  6. Dover, J. S., et al. Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  7. SOLTA Medical. (2016) Thermage FLX™ System Model Number: TG-3A User Manual. USA: SOLTA Medical
  8. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.


HER WORLD / HARPER’S BAZAAR / FEMALE / NUYOU ADVERTORIAL OCTOBER 2020
 
References:
  1. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  2. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  3. Dover, J. S., et al. (2007) Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  4. Data on file. (2017) Thermage and Ultherapy stats.
  5. Data on file. (2017) Consumables Data.
  6. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  7. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  8. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.
  9. Data on file. (2017) Support for Thermage FLX product feature claims. 28 September.
  10. Data on file. (2009) Report on Gazelle Clinical Study. 09-019-ER. July.
  11. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373.
  12. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.​

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.


TATLER SINGAPORE ADVERTORIAL JUNE 2020


References:


  1. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  2. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.
  3. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373
  4. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  5. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  6. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  7. Dover, J. S., et al. Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  8. SOLTA Medical. (2016) Thermage FLX™ System Model Number: TG-3A User Manual. USA: SOLTA Medical
  9. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.


​
HARPER’S BAZAAR/ICON/THE PEAK ADVERTORIAL SEP 2020
 
References:


  1. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  2. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  3. Dover, J. S., et al. (2007) Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  4. Data on file. (2017) Thermage and Ultherapy stats.
  5. Data on file. (2017) Consumables Data.
  6. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  7. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  8. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.
  9. Data on file. (2017) Support for Thermage FLX product feature claims. 28 September.
  10. Data on file. (2009) Report on Gazelle Clinical Study. 09-019-ER. July.
  11. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373.
  12. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.



Harper’s Bazaar / HER WORLD / ICON – December 2019 issue

References:


  1. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  2. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  3. Dover, J. S., et al. (2007) Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  4. Data on file. (2017) Thermage and Ultherapy stats.
  5. Data on file. (2017) Consumables Data.
  6. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  7. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  8. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.
  9. Data on file. (2017) Support for Thermage FLX product feature claims. 28 September.
  10. Data on file. (2009) Report on Gazelle Clinical Study. 09-019-ER. July.
  11. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373.
  12. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.
​


Harper’s Bazaar

References:

  1. Data on file. (2017) Support for Thermage FLX product feature claims. 28 September.
  2. Dover, J. S., et al. (2007) Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  3. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Non-ablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  4. Melzack, R and Wall, P, D. (1965) Pain Mechanisms: A New Theory. Science, new Series. Vol. 150, pp. 971-979.
  5. Data on file. (2009) Report on Gazelle Clinical Study. 09-019-ER. July.
  6. SOLTA Medical. (2016) Thermage FLX™ System Model Number: TG-3A User Manual. USA: SOLTA Medical
  7. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Non-ablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  8. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  9. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373.
  10. Data on file. (2017) Efficacy and safety of Thermage nonsurgical radiofrequency treatment for skin tightening and rhytide reduction of the body. 13 November.
  11. Data on file. (2017) Consumables Data.
  12. U. S. Food and Drug Administration/Department of Health & Human Services. (2013) Section 510(k) Thermage CPT System (TG-2B). K132431. 6 September.
  13. The Aesthetic Guide (2017) The Aesthetic Industry Awards 2019 Winners. TAG [online]. Available from: http://edition.pagesuite.professional.co.uk/html5/reader/production/default.aspx?pnum=56&edid=9 [Accessed 12th November 2017]
  14. Bogle, M. A., et al. (2007) Evaluation of the Multiple Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Wiley InterScience. DOI 10.1002, pp. 210-217.
  15. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with No ablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.



HER WORLD

References:

  1. Zelickson, B. D., et al. (2010) Histological and Ultrastructural Evaluation of the Effects of a Radiofrequency-based Nonablative Dermal Remodeling Device. Arch Dermatol. Vol 140, pp.204-209.
  2. Finzi, E., Spangler, A. (2005) Multipass Vector (Mpave) Technique with Nonablative Radiofrequency to Treat Facial and Neck Laxity. The American Society for Dermatologic Surgery. Vol 31, pp. 916-922.
  3. Dover, J. S., et al. (2007) Results of a Survey of 5700 Patient Monopolar Radiofrequency Facial Skin Tightening Treatments. The American Society for Dermatologic Surgery. Vol 33, pp. 900-907.
  4. Data on file. (2017) Thermage and Ultherapy stats.
  5. Data on file. (2017) Consumables Data.
  6. Data on file. (2017) Section 510(k). Thermage FLX System. FDA. K170758. 22 September.
  7. Fitzpatrick, R. D. et al. (2003) Multicenter Study of Noninvasive Radiofrequency for Periorbital Tissue Tightening. Lasers in Surgery and Medicine. 33, pp.232-242.
  8. Sasaki G., et al. (2007). Clinical Parameters for Predicting Efficacy and Safety with Nonablative Monopolar Radiofrequency Treatments to the Forehead, Face, and Neck. Aesthetic Surgery Journal, 27, 376-387.
  9. Data on file. (2017) Support for Thermage FLX product feature claims. 28 September.
  10. Data on file. (2009) Report on Gazelle Clinical Study. 09-019-ER. July.
  11. Fritz, M., Counters, J. T., Zelickson, B. D. (2004) Radiofrequency Treatment for Middle and Lower Face Laxity. Arch Facial Plastic Surg. Vol. 6, pp370-373.
  12. Bogle, A, M et al. (2007) Evaluation of the Multi Pass, Low Fluence Algorithm for Radiofrequency Tightening of the Lower Face. Lasers in Surgery and Medicine. Vol 39, pp. 210-217.

IMPORTANT SAFETY INFORMATION
Side effects are generally mild, and may include redness, swelling and mild/moderate pain during treatment. Potential risks including itching, blanching, blisters, bumps, burns, scabbing, scarring, bruising pigment changes, altered sensations, surface irregularities and herpes reactivations.